Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Rhea-AI Summary

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company focused on developing next-generation programmed T cell therapies, has announced its plans to release second quarter 2024 financial results and operational highlights. The release is scheduled for Thursday, August 8, 2024, before US markets open. Following the release, the company will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the financial results and provide a general business update. Interested participants are advised to pre-register for the conference call to receive dial-in numbers and a personal PIN. An audio webcast and replay will also be available on the events section of Autolus' website.

News Market Reaction – AUTL

+1.52%

+1.52% Session move

In the trading session that priced this news, AUTL gained 1.52%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, July 26, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2024 financial results and operational highlights before open of US markets on Thursday, August 8, 2024.

Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

Contact:

Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com

Julia Wilson
+44 (0) 7818 430877 
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303 
susan@sanoonan.com

FAQ

When will Autolus Therapeutics (AUTL) release its Q2 2024 financial results?

Autolus Therapeutics (AUTL) will release its second quarter 2024 financial results before US markets open on Thursday, August 8, 2024.

What time is the Autolus Therapeutics (AUTL) Q2 2024 earnings call scheduled for?

Autolus Therapeutics (AUTL) will host its Q2 2024 earnings conference call and webcast on August 8, 2024, at 8:30 am EDT/1:30 pm BST.

How can investors access Autolus Therapeutics' (AUTL) Q2 2024 earnings call?

Investors can pre-register for the conference call to receive dial-in numbers and a personal PIN. Additionally, a simultaneous audio webcast and replay will be accessible on the events section of Autolus' website.

What will be discussed during Autolus Therapeutics' (AUTL) Q2 2024 earnings call?

During the Q2 2024 earnings call, Autolus Therapeutics' (AUTL) management will discuss the company's financial results and provide a general business update.